FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 353:221-224 July 21, 2005 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

On October 4, 2001, Joshua Oukrop, a Minnesota teenager with hypertrophic cardiomyopathy and a high risk of sudden death from ventricular fibrillation, received an implantable cardioverter–defibrillator (ICD). The device was a Ventak Prizm 2 DR Model 1861 manufactured by Guidant (Indianapolis). After it was implanted, Oukrop's physicians at the Minneapolis Heart Institute Foundation checked it every three months (most recently on January 31, 2005) and found no problems.¹

On March 14, 2005, Oukrop, then a 21-year-old college student, collapsed and died in a remote area of southeastern Utah during a spring-break bicycling trip with his girlfriend.^1,2 An autopsy revealed no . . . [Full Text of this Article]

Source Information

Dr. Steinbrook is a national correspondent for the Journal.

This article has been cited by other articles:

• Kelley, A. S., Mehta, S. S., Carrington Reid, M. (2009). Management of Patients with ICDs at the End of Life (EOL): A Qualitative Study. AM J HOSP PALLIAT CARE 25: 440-446 [Abstract]  
• Boriani, G., Biffi, M., Marziali, A., Diemberger, I., Martignani, C. (2009). A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. Europace 11: 1-3 [Full Text]  
• Padera, R. F. Jr., Schoen, F. J. (2008). Pathology of Cardiac Surgery. Card Surg Adult 3: 111-178 [Full Text]  
• Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., Boriani, G., Estes, N. A. M. III, Favale, S., Piccininno, M., Winters, S. L., Santini, M., Betocchi, S., Arribas, F., Sherrid, M. V., Buja, G., Semsarian, C., Bruzzi, P. (2007). Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. JAMA 298: 405-412 [Abstract] [Full Text]  
• Myerburg, R. J., Feigal, D. W. Jr., Lindsay, B. D. (2006). Life-Threatening Malfunction of Implantable Cardiac Devices. NEJM 354: 2309-2311 [Full Text]  
• Kirkpatrick, J. N., Burke, M. C., Knight, B. P. (2006). Postmortem Analysis and Retrieval of Implantable Pacemakers and Defibrillators. NEJM 354: 1649-1650 [Full Text]  
• Scheinman, M. M., Keung, E. (2006). The Year in Clinical Electrophysiology. J Am Coll Cardiol 47: 1207-1213 [Full Text]  
• Goldberger, Z., Lampert, R. (2006). Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies. JAMA 295: 809-818 [Abstract] [Full Text]  
• Hauser, R. G., Maron, B. J. (2005). Lessons From the Failure and Recall of an Implantable Cardioverter-Defibrillator. Circulation 112: 2040-2042 [Full Text]  
• (2005). Disclosure and performance: expecting more, and better. CMAJ 173: 457-457 [Full Text]  
• (2005). Divulgation et rendement : on s'attend a plus et mieux. CMAJ 173: 459-459 [Full Text]  
• Gehi, A., Haas, D., Fuster, V. (2005). Primary Prophylaxis With the Implantable Cardioverter-Defibrillator: The Need for Improved Risk Stratification. JAMA 294: 958-960 [Full Text]